Smith & Nephew PLC
SNN
Company Profile
Business description
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Contact
Hatters Lane
Building 5, Croxley Park
WatfordHertfordshireWD18 8YE
GBRT: +44 1923477100
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
17,349
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,586.70 | 15.30 | 0.18% |
CAC 40 | 7,734.40 | 130.04 | -1.65% |
DAX 40 | 23,629.58 | 369.59 | -1.54% |
Dow JONES (US) | 41,603.07 | 256.02 | -0.61% |
FTSE 100 | 8,717.97 | 21.29 | -0.24% |
HKSE | 23,601.26 | 56.95 | 0.24% |
NASDAQ | 18,737.21 | 188.53 | -1.00% |
Nikkei 225 | 37,160.47 | 174.60 | 0.47% |
NZX 50 Index | 12,596.50 | 65.75 | -0.52% |
S&P 500 | 5,802.82 | 39.19 | -0.67% |
S&P/ASX 200 | 8,360.90 | 12.20 | 0.15% |
SSE Composite Index | 3,348.37 | 31.82 | -0.94% |